Navigation Links
Hospira Reports Third-Quarter 2012 Results
Date:11/7/2012

LAKE FOREST, Ill., Nov. 7, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the third quarter ended Sept. 30, 2012. Net sales for the quarter were $994 million, and adjusted* diluted earnings per share were $0.47. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.) Diluted earnings per share on a Generally Accepted Accounting Principles (GAAP) basis were $0.01.

"Results for the third quarter were in line with our expectations, and we continued to advance our overall quality improvement initiatives," said F. Michael Ball, chief executive officer. "We remain fully committed to reinforcing Hospira's foundation, and we believe we are making progress in this regard. As we head toward the end of what has been a challenging year for Hospira, I am pleased with our dedicated focus, the improvements we are making across the organization and the advancements of Hospira's growth expansion initiatives. I remain confident that our actions are positioning Hospira to be a stronger, more competitive global company, one that will serve the needs of our customers and patients, and deliver strong value to our shareholders."

Third-Quarter 2012 ResultsThe following table highlights selected financial results for the third quarter of 2012 compared to the same period in 2011:In $ millions,

except per share

amounts

GAAP

Three Months Ended

September 30, Adjusted*

Three Months Ended

September 30,2012

2011

%

Change

2012

2011

%

ChangeNet Sales

$994.0

$976.7

1.8%

n/a

n/a

n/aGross Profit (Net Sales less

Cost of Products Sold)'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Reports First-Quarter 2012 Results
3. Hospira to Present at Upcoming Investor Conferences
4. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
5. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
6. Hospira to Host Conference Call for Second-quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira Reports Second-Quarter 2012 Results
9. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Konica Minolta ... announced today a new, integrated portable X-ray ... solution is now available with a larger integrated console, ... mounted system offers a larger viewing area to simplify ... provides additional space for accessories and storage, along with ...
(Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
Breaking Medicine Technology:Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 3Web Industries Receives 3M Preferred Converter Status 2
... advanced leukemia and myelodysplastic, syndrome patients presented ... N.J., Dec. 10 Celator Pharmaceuticals today,announced results ... a liposomal,formulation that incorporates a synergistic ratio of ... and myelodysplastic,syndromes. While dose escalation in the study ...
... Dec. 10 The US Food and,Drug Administration ... small,open, long-term, clinical studies in patients with gastro-esophageal ... study) or NEXIUM(R) (LOTUS study) treatment., AstraZeneca ... conclusion which states,"FDA continues to conclude that long-term ...
Cached Medicine Technology:Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 2FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 3FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium) 4
(Date:3/3/2015)... Daylight Savings Time may lead to your kids ... for parents. , Parents and their children may feel a ... they set their clocks forward one hour for Daylight Savings ... one hour earlier -- you will have already lost one ... about “sleep hygiene” for their kids and teens this week, ...
(Date:3/3/2015)... 03, 2015 Topical BioMedics, Inc., announces its ... streamed live on Tuesday, March 10th, 12pm – 1pm and ... and accessible 24/7. , The Pain Management ... for the March 10th workshop is “Opioid Addiction: An ... the U.S. represents 5% of the world’s population, yet consumers ...
(Date:3/3/2015)... MD (PRWEB) March 03, 2015 Today ... Association (ASHA) is using the occasion to applaud and ... campaign by the World Health Organization (WHO) for stemming ... campaign aims to encourage young people to practice safe ... audio technology, attending concerts or sporting events, or engaging ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The ... better predict antidepressant treatment outcomes for patients with ... than any of the individual genes that comprise ... investigators from the Mayo Clinic and Assurex Health, ... , The proprietary technology of the GeneSight ...
(Date:3/3/2015)... With a grant of more than $4.5 ... has been named a national coordinating center by the ... for Health: Improving Community Health Through Innovations in Financing ... health and reduce disparities through innovations in collaboration and ... of the center and up to 10 communities over ...
Breaking Medicine News(10 mins):Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2
... have now proved using a specialized mouse model that ... neurons.// The results of this study have for the ... ,Also known as apoE, this cholesterol-carrying protein ... the major known genetic risk factor for Alzheimer's disease, ...
... published in the journal Carcinogenesis show that exercise can offer ... that had a round the clock access to wheels took ... that exercise and a restricted diet had a healthy effect ... ,The first study exposed mice to ultraviolet B ...
... Dental Health Foundation has found that more than 60 percent ... clean off food debris// struck in between their teeth. Items ... use, the survey said. ,More disturbingly, the survey ... teeth giving rise to oral health problems and bad breath. ...
... the form of health claims that green tea is no ... a model qualified health// claim says "Daily consumption of at ... a source of catechins may reduce a number of risk ... evidence is supportive, but not conclusive, for this claim. (Green ...
... (AIIMS) here is running short of faculty members and its ... informed Friday. ,Replying to a question, minister of state ... AIIMS was running with just 479 faculty members as against ... the house that during 2003-05, 20 faculty members had either ...
... rate in Madhya Pradesh, Bhopal Archbishop Pascal Topno has ... ,With 13,000 reported deaths every year during or ... is one of the highest in the country. ... Niketan Welfare Centre here, Topno urged them to tap ...
Cached Medicine News:Health News:Alzheimer's-linked apolipoprotein E produced by neurons, Gladstone study 2Health News:Green tea’s health claims questioned: FD 2Health News:Green tea’s health claims questioned: FD 3
Cushing bayonet....
Straight, blunt tips....
Angled, pointed, with attached cable for Valleylab and other brands generators....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Medicine Products: